-
1 Comment
Menicon Co., Ltd is currently in a long term uptrend where the price is trading 13.7% above its 200 day moving average.
From a valuation standpoint, the stock is 95.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.9.
Menicon Co., Ltd's total revenue rose by 6.7% to $22B since the same quarter in the previous year.
Its net income has increased by 70.8% to $2B since the same quarter in the previous year.
Based on the above factors, Menicon Co., Ltd gets an overall score of 4/5.
Exchange | TSE |
---|---|
CurrencyCode | JPY |
ISIN | JP3921270009 |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Target Price | 2140 |
---|---|
Dividend Yield | 4.3% |
Beta | 0.44 |
Market Cap | 91B |
PE Ratio | 19.42 |
Menicon Co., Ltd. manufactures and sells contact lenses and lens care products. The company offers its products to hospitals, ophthalmology clinics, contact lens stores, eyeglass stores, and drug stores. It exports its products in 80 countries, including the United States, Europe, Oceania, and Asia. Menicon Co., Ltd. was incorporated in 1943 and is headquartered in Nagoya, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 7780.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025